BioSyent Inc. (TSXV:RX)
Canada flag Canada · Delayed Price · Currency is CAD
11.64
-0.06 (-0.51%)
Jun 26, 2025, 2:41 PM EDT

BioSyent Company Description

BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Its products include FeraMAX 150, an oral hematinic; FeraMAX Powder, a water soluble oral iron supplement, which helps the body form red blood cells; and FeraMAX Pd Therapeutic 150 for the prevention and treatment of iron deficiency anemia.

It also offers Cathejell, a product indicated for surface anesthesia and lubrication during various procedures, including cystoscopy, catheterization, endourethral operation, endoscopy, proctoscopy, rectoscopy, and tracheal intubation, as well as used for the symptomatic treatment of pain in connection with cystitis and urethritis; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by menopause, stress, and chemotherapy; and Proktis-M, a rectal suppository for the healing of the anus and rectum.

In addition, it provides Combogesic for moderate acute pain and reduction of fever in adults; Protect-It, a non-chemical food-safe grain insecticide product used as a preventative treatment against insect infestations in stored grains; and Tibella, a hormone replacement therapy to treat vasomotor symptoms due to estrogen deficiency.

The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006 to reflect its forward focus on the pharmaceutical market.

BioSyent Inc. was incorporated in 2006 and is headquartered in Mississauga, Canada.

BioSyent Inc.
Country Canada
Founded 2006
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
CEO René Goehrum

Contact Details

Address:
2476 Argentia Road
Mississauga, British Columbia British Columbia
Canada
Phone 905-206-0013

Stock Details

Ticker Symbol RX
Exchange TSX Venture Exchange
Fiscal Year January - December
Reporting Currency CAD
ISIN Number CA0906901081
SIC Code 2834

Key Executives

Name Position
René C. Goehrum Chairman, Chief Executive Officer and President
Robert J. March Vice President of Finance and Chief Financial Officer
Joost van der Mark Vice President of Corporate Development
Marnie Mccormick Vice President and GM
Kevin Wilson Vice President of Sales
Neelu Atwal Director of Human Resources